Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome

Alimentary Pharmacology and Therapeutics

Volumn 35, Issue 7, 2012, Pages 828-838

  Chassard, C ^a   Dapoigny, M ^b   Scott, K P ^c   Crouzet, L ^a   Del'Homme, C ^a   Marquet, P ^a   Martin, J C ^c   Pickering, G ^d   Ardid, D ^d   Eschalier, A ^d   Dubray, C ^d   Flint, H J ^c   Bernalier Donadille, A ^a  

^a CEMAGREF   (France)

^b HÔTEL DIEU   (France)

^c ROWETT RESEARCH INSTITUTE   (United Kingdom)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA 16S;

ADULT; ANAEROBE; ARTICLE; BACTERIAL CELL; BACTERIAL COUNT; BACTERIUM DETECTION; CONSTIPATION; CONTROLLED STUDY; ENTEROBACTERIACEAE; ENZYME DEGRADATION; ENZYME SYNTHESIS; FECES ANALYSIS; FECES MICROFLORA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TARGETING; HUMAN; INTESTINE FLORA; IRRITABLE COLON; LACTIC ACID BACTERIUM; MICROBIAL COMMUNITY; PRIORITY JOURNAL;

ADULT; CASE-CONTROL STUDIES; CONSTIPATION; FECES; FEMALE; GASTROINTESTINAL TRACT; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; IRRITABLE BOWEL SYNDROME; MALE; METAGENOME; MIDDLE AGED; YOUNG ADULT;

EID: 84862829772     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2012.05007.x     Document Type: Article

References (46)

1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC,. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
2. Inadomi JM, Fennerty MB, Bjorkman D,. Systematic review: the economic impact of irritable bowel syndrome. Aliment Pharmacol Ther 2003; 18: 671-82. (Pubitemid 37271832)
3. Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, (eds). Rome II: The functional gastrointestinal disorders, 2nd edn. Degnon Associates: Mclean, VA, 2000; 764.
4. Karantanos T, Markoutsaki T, Gazouli M, Anagnou NP, Karamanolis D,. Current insights in to the pathophysiology of Irritable Bowel Syndrome. Gut Pathog 2010; 2: 1-8.
5. Lyra A, Rinttilä T, Nikkilä J, et al,. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16D rRNA gene phylotype quantification. World J Gastroenterol 2009; 15: 5936-45.
6. Salonen A, de Vos WM, Palva A,. Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology 2010; 156: 3205-15.
7. Joossens M, Hyus G, Cnockaert M, et al,. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 2010; 60: 631-7.
8. Larsen N, Vogesen FK, van den Berg FWJ, et al,. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 2010; 5: e9085.
9. Si JM, Yu YC, Fan YJ, Chen S-J,. Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol 2004; 10: 1802-5. (Pubitemid 38931209)
10. Malinen E, Rintttilä T, Kajander K, et al,. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005; 100: 373-82. (Pubitemid 40314522)
11. Maukonen J, Satokari R, Mätto J, Söderlund H, Mattila-Sandholm T, Saarela M,. Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria. J Med Microbiol 2006; 55: 625-33.
12. Kassinen A, Krogius Kurikka L, Makivuokko H, et al,. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007; 133: 24-33. (Pubitemid 47031125)
13. Kerckhoffs APM, Samsom M, Van der Rest M, et al,. Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol 2009; 15: 2887-92.
14. Codling C, O'Mahony L, Shanahan F, Quigley EMM, Marchesi JR,. A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome. Dig Dis Sci 2010; 55: 392-7.
15. Duncan SH, Louis P, Flint HJ,. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol 2004; 70: 1136-42.
16. Belenguer A, Duncan SH, Calder AG, et al,. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol 2006; 72: 3593-9. (Pubitemid 43728015)
17. 2 and acetate transfers during xylan fermentation between a butyrate-producing xylanolytic species and hydrogenotrophic microorganisms from the human gut. FEMS Microbiol Lett 2006; 254: 116-22.
18. 2 in the large intastine. Gastroenterology 1992; 102: 1269-77.
19. Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, Fukudo S,. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil 2010; 22: 512-5.
20. King TS, Elia M, Hunter JO,. Abnormal colonic fermentation in irritable bowel syndrome. Lancet 1998; 352: 1187-9. (Pubitemid 28458534)
21. Dapoigny M, Stockbrügger RW, Azpiroz F, et al,. Role of alimentation in irritable bowel syndrome. Digestion 2003; 67: 225-33. (Pubitemid 37100203)
22. Chassard C, Scott KP, Marquet P, et al,. Assessment of metabolic diversity within the intestinal microbiota from healthy humans using combined molecular and cultural approaches. FEMS Microbiol Ecol 2008; 66: 496-504.
23. Hungate RE,. A roll tube method for the cultivation of strict anaerobes. In:, Norris J R, Ribbons DW, (eds). Methods in Microbiology, vol. 3B. Academic Press: London/New-York, 1969; 117-32.
24. Clarke KR, Owens JP,. A simple and versatile microcomputer for the determination of Most Probable Number. J Microbiol Methods 1983; 1: 133-7. (Pubitemid 13024696)
25. Leedle JA, Hespell RB,. Differential carbohydrate media and anaerobic replica plating techniques in delineating carbohydrate utilizing subgroups in rumen bacterial populations. Appl Environ Microbiol 1980; 39: 709-19. (Pubitemid 10038156)
26. Robert C, Bernalier-Donadille A,. The cellulolytic microflora of the human colon: evidence of microcrystalline cellulose-degrading bacteria in methane-excreting subjects. FEMS Microbiol Ecol 2003; 46: 81-9. (Pubitemid 37297723)
27. Chassard C, Goumy V, Leclerc M, Del'homme C, Bernalier-Donadille A,. Characterization of the xylan-degrading microbial community from human faeces. FEMS Microbiol Ecol 2007; 61: 121-31. (Pubitemid 46889818)
28. Matulova M, Nouaille R, Capek P, Péan M, Forano E, Delort AM,. Degradation of wheat straw by Fibrobacter succinogenes S85: a liquid and solid NMR study. Appl Environ Microbiol 2005; 71: 1247-53. (Pubitemid 40396662)
29. 2-utilizing acetogenic bacteria from the digestive tract of animals and man. FEMS Microbiol Lett 1995; 15: 7-12.
30. Gibson GR, Macfarlane GT,. Chemostat enrichment of sulphate-reducing bacteria from the large gut. Lett Appl Microbiol 1988; 7: 127-33. (Pubitemid 19025352)
31. Duncan SH, Scott KP, Ramsay AG, et al,. Effects of alternative dietary substrates on competition between human colonic bacteria in an anaerobic fermentor system. Appl Environ Microbiol 2003; 69: 1136-42. (Pubitemid 36204845)
32. Walker AW, Duncan SH, McWilliam Leitch EC, Child MW, Flint HJ,. pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Appl Environ Microbiol 2005; 71: 3692-700. (Pubitemid 40980536)
33. Aminov RI, Walker AW, Duncan SH, Harmsen HJ, Welling GW, Flint HJ,. Molecular diversity, cultivation, and improved detection by fluorescent in situ hybridization of a dominant group of human gut bacteria related to Roseburia spp. or Eubacterium rectale. Appl Environ Microbiol 2006; 72: 6371-6. (Pubitemid 44414672)
34. Balsari A, Ceccarelli A, Dubini F, Fesce E, Poli G,. The fecal population in the irritable bowel syndrome. Microbiologica 1982; 5: 185-94. (Pubitemid 13228114)
35. Mättö J, Maunuksela L, Kajander K, et al,. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome-a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol 2005; 43: 213-22. (Pubitemid 40170291)
36. Marquet P, Duncan SH, Chassard C, Bernalier-Donadille A, Flint HJ,. Lactate has the potential to promote hydrogen sulphide formation in the human colon. FEMS Microbiol Lett 2009; 299: 128-34.
37. Nakamura N, Lin HC, McSweeney CS, Mackie RI, Gaskins HR,. Mechanisms of microbial hydrogen disposal in the human colon and implications for health and diseases. Annu Rev Food Sci Technol 2010; 1: 363-95.
38. Bourriaud C, Robins R, Martin L, et al,. Lactate is mainly fermented to butyrate by human intestinal microflora but inter-individual variation is evident. J Appl Microbiol 2005; 99: 201-12. (Pubitemid 40897005)
39. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ,. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 2008; 27: 104-19. (Pubitemid 350256609)
40. Roediger WEW, Duncan A, Kapaniris O, Millard S,. Sulphide impairment of substrate oxidation in rat colonocytes: a biochemical basis for ulcerative colitis. Clin Sci 1993; 85: 623-7. (Pubitemid 23336549)
41. Azpiroz F, Bouin M, Camilleri M, et al,. Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil 2007; 19 (Suppl. 1): 62-88. (Pubitemid 46058983)
42. Matsunami M, Tarui T, Mitani K, et al,. Luminal hydrogen sulfide plays a pro-nociceptive role in mouse colon. Gut 2009; 58: 551-61.
43. Gibson GR, Cummings JH, Macfarlane GT,. Growth and activities of sulphate-reducing bacteria in gut contents of healthy and patients with ulcerative colitis. FEMS Microbiol Ecol 1991; 86: 103-12.
44. Loubinoux J, Bronowicki JP, Pereira IA, Mougenel JL, Le Faou AE,. Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases. FEMS Microbiol Ecol 2002; 40: 107-12. (Pubitemid 34607174)
45. El Oufir L, Flourié B, Bruley Des Varannes S, et al,. Relations between transit time, fermentation products, and hydrogen consuming flora in healthy humans. Gut 1996; 38: 870-7. (Pubitemid 26231772)
46. Child MW, Kennedy A, Walker AW, Bahrami B, Macfarlane S, Macfarlane GT,. Studies in the effect of retention time on bacterial populations colonizing a three-stage continuous culture model of the human large gut using FISH techniques. FEMS Microbiol Ecol 2006; 55: 299-310.